Is N,N-dimethylglycine N-oxide a choline and betaine metabolite?

References

Atkinson, W., Elmslie, J., Lever, M., Chambers, S.T., and George, P.M. (2008). Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and post methionine load conditions in healthy male subjects. Am. J. Clin. Nutr. 87, 577–585.10.1093/ajcn/87.3.577Search in Google Scholar

Day, C.R. and Kempson, S.A. (2016). Betaine chemistry, roles, and potential use in liver disease. Biochim. Biophys. Acta 1860, 1098–1106.10.1016/j.bbagen.2016.02.001Search in Google Scholar

Ejaz, A., Martinez-Guino, L., Goldfine, A.B., Ribas-Aulinas, F., De Nigris, V., Ribó, S., Gonzalez-Franquesa, A., Garcia-Roves, P.M., Li, E., Dreyfuss, J.M., et al. (2016). Dietary betaine supplementation increases fgf21 levels to improve glucose homeostasis and reduce hepatic lipid accumulation in mice. Diabetes 65, 902–912.10.2337/db15-1094Search in Google Scholar

Hoffmann, L., Brauers, G., Gehrmann, T., Häussinger, D., Mayatepek, E., Schliess, F., and Schwahn, B.C. (2013). Osmotic regulation of hepatic betaine metabolism. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G835–G846.10.1152/ajpgi.00332.2012Search in Google Scholar

Ikutani, Y. and Matsumura, E. (1968). Studies on the syntheses of N,N-dialkyl neutral amino acids and corresponding N-oxides. Memoirs Osuku Kyoiku Univ. 17, 81–88.Search in Google Scholar

Konstantinova, S.V., Tell, G.S., Vollset, S.E., Nygård, O., Bleie, Ø., and Ueland, P.M. (2008). Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J. Nutr. 138, 914–920.10.1093/jn/138.5.914Search in Google Scholar

Lever, M. and Slow, S. (2010). The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Clin. Biochem. 43, 732–744.10.1016/j.clinbiochem.2010.03.009Search in Google Scholar

Lever, M., McEntyre, C.J., George, P.M, Slow, S., Chambers, S.T., and Foucher, C. (2014a). Fenofibrate causes elevation of betaine excretion but not excretion of other osmolytes by healthy adults. J. Clin. Lipidol. 8, 433–440.10.1016/j.jacl.2014.04.001Search in Google Scholar

Lever, M., McEntyre C.J., George, P.M., Slow S., Elmslie, J.L., Lunt, H., Chambers S.T., Parry-Strong, A., and Krebs. J.D. (2014b). Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes. Cardiovasc. Drugs Ther. 28, 459–468.10.1007/s10557-014-6542-9Search in Google Scholar

Mackay, R.J., McEntyre, C.J., Henderson, C., Lever, M., and George, P.M. (2011). Trimethylaminuria: causes and diagnosis of a socially distressing condition. Clin. Biochem. Rev. 31, 3–13.Search in Google Scholar

Mackenzie, C.G. and Frisell, W.R. (1958). The metabolism of dimethylglycine by liver mitochondria. J. Biol. Chem. 232, 417–427.10.1016/S0021-9258(18)70407-9Search in Google Scholar

McEntyre, C.J., Lever, M., Chambers, S.T., George, P.M., Slow, S., Elmslie, J.L., Florkowski, C.M., Lunt, H., and Krebs, J.D. (2015). Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period. Ann. Clin. Biochem. 52, 352–360.10.1177/0004563214545346Search in Google Scholar PubMed

Obeid, R., Awwad, H.M., Rabagny, Y., Graeber, S., Herrmann, W., and Geisel, J. (2016). Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism. Am. J. Clin. Nutr. 103, 703–711.10.3945/ajcn.115.121269Search in Google Scholar PubMed

Svingen, G.F.T., Ueland, P.M., Pedersen, E.K.R., Schartum-Hansen, H., Seifert, R., Ebbing, M., Løland, K.H., Tell, G.S., and Nygård, O. (2013). Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris. Arterioscler. Thromb. Vasc. Biol. 33, 2041–2048.10.1161/ATVBAHA.113.301714Search in Google Scholar PubMed

Svingen, G.F., Schartum-Hansen, H., Ueland, P.M., Pedersen, E.R., Seifert, R., Ebbing, M., Bønaa, K.H., Mellgren, G., Nilsen, D.W., Nordrehaug, J.E., et al. (2015). Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease. Eur. J. Prev. Cardiol. 22, 743–752.10.1177/2047487314529351Search in Google Scholar PubMed

Svingen, G.F.T., Schartum-Hansen, H., Pedersen, E.R., Ueland, P.M., Tell, G.S., Mellgren, G., Njølstad, P.R., Seifert, R., Strand, E., Karlsson, T., et al. (2016). Prospective associations of systemic and urinary choline metabolites with incident type 2 diabetes. Clin. Chem. 62, 755–765.10.1373/clinchem.2015.250761Search in Google Scholar PubMed

Sweeley, C.C. and Horning, E.C. (1957). Rearrangement and decarboxylation reactions of N,N-dimethylglycine oxide. J. Am. Chem. Soc. 79, 2620–2625.10.1021/ja01567a071Search in Google Scholar

Tang, W.H., Wang, Z., Levison, B.S., Koeth, R.A., Britt, E.B., Fu, X., Wu, Y., and Hazen, S.L. (2013). Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368, 1575–1584.10.1056/NEJMoa1109400Search in Google Scholar PubMed PubMed Central

Tang, W.H., Wang, Z., Fan, Y., Levison, B., Hazen, J.E., Donahue, L.M., Wu, Y, and Hazen, S.L. (2014). Prognostic value of elevated levels of intestinal microbe-generated metabolite, trimethylamine-N-oxide (TMAO), in patients with heart failure: refining the gut hypothesis. J. Am. Coll. Cardiol. 64, 1908–1914.10.1016/j.jacc.2014.02.617Search in Google Scholar PubMed PubMed Central

Tang, W.H., Wang, Z., Shrestha, K., Borowski, A.G., Wu, Y., Troughton, R.W., Klein, A.L., and Hazen, S.L. (2015). Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. J. Card. Fail. 21, 91–96.10.1016/j.cardfail.2014.11.006Search in Google Scholar PubMed PubMed Central

Ueland, P.M. (2011). Choline and betaine in health and disease. J. Inherit. Metab. Dis. 34, 3–15.10.1007/s10545-010-9088-4Search in Google Scholar PubMed

Walford, G.A., Ma, Y., Clish, C., Florez, J.C., Wang, T.J., Gerszten R.E., for the Diabetes Prevention Program Research Group. (2016). Metabolite profiles of diabetes incidence and intervention response in the diabetes prevention program. Diabetes 65, 1424–1433.10.2337/db15-1063Search in Google Scholar PubMed PubMed Central

Wang, Z., Levison, B.S., Hazen, J.E., Donahue, L., Li, X.-M., and Hazen S.L. (2014a). Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry. Anal. Biochem. 455, 35–40.10.1016/j.ab.2014.03.016Search in Google Scholar

Wang, Z., Tang, W.H., Buffa, J.A., Fu, X., Britt, E.B., Koeth, R.A., Levison, B.S., Fan, Y., Wu, Y., Hazen, S.L. (2014b). Prognostic value of choline and betaine depends on intestinal microbiota generated metabolite trimethylamine-N-oxide. Eur. Heart J. 35, 904–910.10.1093/eurheartj/ehu002Search in Google Scholar

Zeisel, S.H. (2000). Choline: an essential nutrient for humans. Nutrition 16, 669–671.10.1016/S0899-9007(00)00349-XSearch in Google Scholar